Comparison of Battery Electric Vehicles and Fuel Cell Vehicles
World Electric Vehicle Journal · 18.09.2023 · 14 (9) · 262
DOI: 10.3390/wevj14090262 ↗Kurz gefasst
Fachartikel in der Zeitschrift World Electric Vehicle Journal, online erschienen am 18.09.2023. Verfasst von Daniel De Wolf und 1 weiteren Autor:innen. Die Arbeit wurde bisher 77-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
In the current context of the ban on fossil fuel vehicles (diesel and petrol) adopted by several European cities, the question arises of the development of the infrastructure for the distribution of alternative energies, namely hydrogen (for fuel cell electric vehicles) and electricity (for battery electric vehicles). First, we compare the main advantages/constraints of the two alternative propulsion modes for the user. The main advantages of hydrogen vehicles are autonomy and fast recharging. The main advantages of battery-powered vehicles are the lower price and the wide availability of the electricity grid. We then review the existing studies on the deployment of new hydrogen distribution networks and compare the deployment costs of hydrogen and electricity distribution networks. Finally, we conclude with some personal conclusions on the benefits of developing both modes and ideas for future studies on the subject.
Zitieren
APA
Wolf, D. D., & Smeers, Y. (2023). Comparison of Battery Electric Vehicles and Fuel Cell Vehicles. World Electric Vehicle Journal, 14(9), 262. https://doi.org/10.3390/wevj14090262
Vancouver
Wolf DD, Smeers Y. Comparison of Battery Electric Vehicles and Fuel Cell Vehicles. World Electric Vehicle Journal. 2023;14(9):262. doi:10.3390/wevj14090262
BibTeX
@article{Wolf2023,
author = {Wolf, Daniel De and Smeers, Yves},
title = {Comparison of Battery Electric Vehicles and Fuel Cell Vehicles},
journal = {World Electric Vehicle Journal},
year = {2023},
volume = {14},
number = {9},
pages = {262},
doi = {10.3390/wevj14090262}
}
EUVIMED